Full Sized Diagram Located at Bottom of Page
|
In clinical studies, PPC has been shown to have positive effects on plasma lipids and plasma lipoproteins. Moreover, PPC has been shown to contribute to an improved condition of blood glucose, glycosylated hemoglobin, ketone body excretion, and other diabetes-specific parameters by positively affecting the pathological mechanism of specific diabetes-associated disturbances.
As a Membrane Therapeutic, PPC has been shown to be a valuable supplement to the basic treatment of diabetics with insulin or oral anti-diabetics if controlling the diabetes does not lead to a restoration of normal lipid metabolism. |
PPC has been shown to:
Indication: Diabetes-associated dyslipidemia that cannot be completely normalized by insulin or oral antidiabetics, particularly hypertriglyceridemia and hypoalpha-lipoproteinemia; diabetes-induced peripheral, coronary and cerebral circulation disturbances.
Dosage Recommendation: 1.8 to 2.7 grams orally. Once daily at meal time. Take with a little liquid if necessary.
- Have positive affects on plasma lipids and plasma lipoproteins
- Improve the lipoprotein profile in diabetic patients
- Influence reverse cholesterol transport to the liver and may help reduce the consequences of hyperlipidemia
- Have positive decreasing effects in some patients to the sensitivity rate of peripheral tissues to insulin
- Have positive effects on incipient peripheral gangrene
- Protect the liver structures against modification by the aldehydic form of glucose
- Reduce signs of liver damage due to diabetic related tuberculosis
- Cause positive increases in plasma lipid levels in the origin of degenerative vascular complications of diabetes
- Normalize the energy and lipid metabolism in the liver cell mitochondria
- Hypo-LPE effects of PPC were observed in decreasing blood cholesterol and triglycerides
- Protects the insulin-producing pancreatic cells
Indication: Diabetes-associated dyslipidemia that cannot be completely normalized by insulin or oral antidiabetics, particularly hypertriglyceridemia and hypoalpha-lipoproteinemia; diabetes-induced peripheral, coronary and cerebral circulation disturbances.
Dosage Recommendation: 1.8 to 2.7 grams orally. Once daily at meal time. Take with a little liquid if necessary.
